Company Information

Company nameAptahem AB
Business strategyAptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of acute, life-threatening conditions in which a combination of coagulation, inflammation and tissue damage are involved. The company also performs business development activities to identify future collaboration partners and licensing partners. The company’s lead candidate Apta-1 is being developed as an emergency medicine intended to prevent the onset of life-threatening organ and tissue damage in sepsis patients.
CEOMikael Lindstam
Chairman of the BoardBert Junno
BoardBert Junno, Theresa Comiskey Olsen, Johan Lindh, Cristina Glad, Åsa Kornfeld, Jan Nilsson
Personell6
Organisation number556970-5782
Articles of AssociationArticles of Association 2023-06-07. See link below to download (in Swedish)
AddressNorra Vallgatan 58
Zip code211 22
CityMalmö
Websitewww.aptahem.com
E-mailinfo@aptahem.com
Telephone0766-02 01 99

Download the Articles of Association as pdf (in Swedish)